Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2024年7月20日 - 5:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of July 2024 (Report No. 2)
Commission file number: 001-38428
POLYPID LTD.
(Translation of registrant’s name into English)
18 Hasivim Street
Petach Tikva 495376, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CONTENTS
On July 10, 2024, PolyPid.
Ltd., or the Company, delivered written notice to Cantor Fitzgerald & Co., or Cantor Fitzgerald,
to terminate that certain Controlled Equity Offering Sales Agreement, dated July 2, 2021, by and between the Company and Cantor Fitzgerald,
or the Cantor Agreement, effective as of July 15, 2024. Pursuant to the Cantor Agreement, the Company could issue and sell ordinary shares,
no par value, or the Ordinary Shares, having an aggregate offering price of up to $8,706,775 (reduced from $45,000,000) from time to time
through Cantor Fitzgerald. Prior to its termination, the Company received approximately $6.4 million in net proceeds from the sales of
its Ordinary Shares pursuant to the Cantor Agreement. No termination penalties were incurred by the Company in connection with the termination
of the Cantor Agreement.
This
Report is incorporated by reference into the Company’s registration statements on Form F-3 (File No. 333-276826 and
File No. 333-280658) and Form S-8 (File No. 333-239517, File No. 333-271060, File No. 333-277703 and File No. 333-280662) filed with the
Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded
by documents or reports subsequently filed or furnished.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
PolyPid Ltd. |
|
|
|
Date: July 19, 2024 |
By: |
/s/ Dikla Czaczkes Akselbrad |
|
Name: |
Dikla Czaczkes Akselbrad |
|
Title: |
Chief Executive Officer |
PolyPid (NASDAQ:PYPD)
過去 株価チャート
から 10 2024 まで 10 2024
PolyPid (NASDAQ:PYPD)
過去 株価チャート
から 10 2023 まで 10 2024